tiprankstipranks
Trending News
More News >
Gillette India Limited (IN:GILLETTE)
:GILLETTE
India Market
Advertisement

Gillette India Limited (GILLETTE) AI Stock Analysis

Compare
2 Followers

Top Page

IN:GILLETTE

Gillette India Limited

(GILLETTE)

Rating:65Neutral
Price Target:
₹11,043.00
▲(7.50% Upside)
The overall stock score for Gillette India Limited is primarily driven by its strong financial performance, characterized by robust revenue growth and profitability. However, technical analysis indicates bearish momentum, and the high P/E ratio suggests overvaluation, which negatively impacts the score. The absence of earnings call data and corporate events means these factors do not influence the score.

Gillette India Limited (GILLETTE) vs. iShares MSCI India ETF (INDA)

Gillette India Limited Business Overview & Revenue Model

Company DescriptionGillette India Limited (GILLETTE) is a prominent player in the consumer products sector, primarily focusing on grooming and oral care. As a subsidiary of Procter & Gamble, the company is well-known for its high-quality razors, blades, and shaving products under the Gillette brand. Additionally, Gillette India offers a range of oral care products, including toothbrushes and toothpaste, under the Oral-B brand. The company operates in the fast-moving consumer goods industry, catering to both male and female consumers in India.
How the Company Makes MoneyGillette India Limited generates revenue through the sale of grooming and oral care products. The company's primary revenue stream comes from its grooming segment, which includes razors, blades, and other shaving products. These products are marketed under the Gillette brand, which has a strong brand presence and consumer loyalty. In addition to grooming products, Gillette India earns revenue from its oral care segment with products marketed under the Oral-B brand. Key factors contributing to the company's earnings include its extensive distribution network, strategic marketing campaigns, and product innovation. As a subsidiary of Procter & Gamble, Gillette India benefits from the parent company's global expertise in consumer goods and access to significant research and development resources.

Gillette India Limited Financial Statement Overview

Summary
Gillette India Limited exhibits robust financial performance with strong revenue growth, effective cost management, and solid profitability metrics. The balance sheet is stable with low leverage, and the cash flow statements reflect healthy cash generation capabilities. Overall, the company maintains financial health while managing risks associated with reinvestment and growth.
Income Statement
85
Very Positive
Gillette India Limited has demonstrated strong revenue growth, with a consistent increase from 2020 to 2024. The gross profit margin remains robust, reflecting efficient cost management. Net profit margin and EBIT margin have shown healthy figures, indicating profitability and operational efficiency. The company’s ability to sustain growth and maintain profitability metrics suggests a solid financial position within its industry.
Balance Sheet
78
Positive
The balance sheet of Gillette India Limited shows a strong equity base with a favorable debt-to-equity ratio due to minimal debt levels. The equity ratio indicates a solid capital structure, providing financial stability. Return on equity has been healthy, reflecting effective use of shareholder funds. The balance sheet reflects a stable financial position with low leverage, though the relatively unchanged equity levels could indicate limited reinvestment in the business.
Cash Flow
83
Very Positive
Cash flow analysis reveals a positive trajectory with consistent growth in free cash flow over the years. The operating cash flow to net income ratio indicates strong cash generation capability relative to profitability. The company’s ability to convert earnings into cash flow efficiently supports its financial health, providing flexibility for future investments. The free cash flow growth rate has been positive, highlighting effective cash management.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue28.80B29.80B26.33B24.77B22.56B20.09B
Gross Profit16.24B14.97B14.82B9.06B8.68B11.20B
EBITDA8.07B8.36B6.54B5.61B4.90B4.87B
Net Income5.34B5.57B4.12B3.56B2.89B3.10B
Balance Sheet
Total Assets19.18B19.18B18.31B19.16B16.19B13.95B
Cash, Cash Equivalents and Short-Term Investments4.26B4.19B4.73B4.53B2.89B1.64B
Total Debt500.00K500.00K500.00K500.00K1.20M1.60M
Total Liabilities8.95B8.95B8.59B9.27B7.58B6.06B
Stockholders Equity10.23B10.23B9.71B9.89B8.61B7.89B
Cash Flow
Free Cash Flow5.25B3.02B4.42B3.84B3.45B3.53B
Operating Cash Flow5.95B3.46B5.09B4.63B4.62B4.43B
Investing Cash Flow-658.90M-435.20M-491.50M-666.70M-1.12B-793.50M
Financing Cash Flow-6.52B-3.58B-4.40B-2.31B-2.25B-4.30B

Gillette India Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price10272.10
Price Trends
50DMA
10566.58
Negative
100DMA
9470.57
Positive
200DMA
9259.89
Positive
Market Momentum
MACD
-59.60
Positive
RSI
42.77
Neutral
STOCH
23.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:GILLETTE, the sentiment is Negative. The current price of 10272.1 is below the 20-day moving average (MA) of 10678.64, below the 50-day MA of 10566.58, and above the 200-day MA of 9259.89, indicating a neutral trend. The MACD of -59.60 indicates Positive momentum. The RSI at 42.77 is Neutral, neither overbought nor oversold. The STOCH value of 23.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:GILLETTE.

Gillette India Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
₹104.37B34.72
2.23%2.37%23.22%
67
Neutral
₹585.90B42.05
97.64%2.12%-1.45%
65
Neutral
₹334.72B59.42
1.07%13.05%38.04%
63
Neutral
$20.74B14.39-8.06%3.17%2.73%-9.96%
62
Neutral
₹398.25B39.50
21.58%393.14%
59
Neutral
₹138.75B49.43
0.04%49.07%38.71%
58
Neutral
₹109.20B20.05
1.49%2.37%-22.37%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:GILLETTE
Gillette India Limited
10,272.10
2,446.69
31.27%
IN:COLPAL
Colgate-Palmolive (India) Limited
2,154.15
-1,329.06
-38.16%
IN:GODREJIND
Godrej Industries Limited
1,182.45
266.70
29.12%
IN:PGEL
PG Electroplast Limited
489.65
-29.78
-5.73%
IN:PGHL
Procter & Gamble Health Ltd.
6,287.40
1,163.87
22.72%
IN:WELSPUNLIV
Welspun Living Limited
113.85
-66.44
-36.85%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 15, 2025